WASHINGTON, United States — US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years.
In March, the company announced results from a trial that showed the two-shot regimen was found to be safe and produced a strong immune response. Moderna said these were similar to vaccine efficacy estimates in adults during Omicron, and it is also currently studying booster doses for all pediatric cohorts.Back in February, the Food and Drug Administration postponed a meeting of a panel to consider the Pfizer-BioNTech Covid vaccine for children younger than five, saying it wanted to see data on how three doses performed before considering the matter.
The picture is further complicated by the fact that Moderna’s vaccine is currently authorized only for adults aged 18 and up in the US, while Pfizer’s is available to those five and up. Moderna is separately seeking authorization for older children.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.